Literature DB >> 1847843

Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.

V Feyles1, W T Dixon, L K Sikora, R C McGarry, L M Jerry.   

Abstract

We have described two human melanoma-associated antigens (HMAA), recognized by the murine monoclonal antibodies LS62 and LS109. LS62 recognizes the neuroglandular antigen (NGA), which is overexpressed in neoplastic melanocytes as well as in several tissues of neuroectodermal origin. These antibodies were used to screen six neuroblastoma cell lines and one neuroepithelioma cell line. A melanoma cell line, G361, known to express the two antigens, was used as the positive control. Variable expression of the two antigens was detected in neuroblastoma cells. The surface expression of NGA and of the LS109 antigen was modulated in parallel with the morphological differentiation induced by retinoic acid, 5-bromodeoxyuridine, or cyclic AMP analog/activators. The modulation of the expression of the two HMAA was detected in G361 melanoma cells and in one of the neuroblastoma cell lines, SK-N-SH. These results suggest altered expression of both antigens during melanoma and neuroblastoma cell differentiation in culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847843     DOI: 10.1007/bf01789043

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  39 in total

1.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.

Authors:  C J Wikstrand; D D Bigner
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

4.  Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

Authors:  V Ciccarone; B A Spengler; M B Meyers; J L Biedler; R A Ross
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

Review 5.  Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus.

Authors:  L P Dehner
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

6.  Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.

Authors:  R C Seeger; H M Rosenblatt; K Imai; S Ferrone
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

7.  Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.

Authors:  L K Sikora; A Pinto; D J Demetrick; W T Dixon; S J Urbanski; W Temple; L M Jerry
Journal:  Int J Cancer       Date:  1987-02-15       Impact factor: 7.396

8.  Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines.

Authors:  R C Seeger; S A Rayner; A Banerjee; H Chung; W E Laug; H B Neustein; W F Benedict
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

9.  Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells.

Authors:  A N Houghton; F X Real; L J Davis; C Cordon-Cardo; L J Old
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  1 in total

1.  Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells.

Authors:  Yavuz Dodurga; Gulsah Gundogdu; Tugba Koc; G Nilufer Yonguc; Vural Kucukatay; N Lale Satiroglu-Tufan
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.